Haemonetics Corp (HAE)
90.75
-1.03
(-1.12%)
USD |
NYSE |
Nov 14, 16:00
91.50
+0.75
(+0.83%)
Pre-Market: 05:31
Haemonetics Free Cash Flow (Quarterly): 39.39M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 39.39M |
| June 30, 2024 | -33.08M |
| March 31, 2024 | 54.40M |
| December 31, 2023 | -40.36M |
| September 30, 2023 | 90.01M |
| June 30, 2023 | 11.40M |
| March 31, 2023 | 67.69M |
| December 31, 2022 | 47.57M |
| September 30, 2022 | 51.08M |
| June 30, 2022 | -3.474M |
| March 31, 2022 | 32.94M |
| December 31, 2021 | 35.77M |
| September 30, 2021 | 22.65M |
| June 30, 2021 | -15.60M |
| March 31, 2021 | -10.08M |
| December 31, 2020 | 56.92M |
| September 30, 2020 | 20.82M |
| June 30, 2020 | 4.116M |
| March 31, 2020 | 35.76M |
| December 31, 2019 | 58.89M |
| September 30, 2019 | 20.43M |
| June 30, 2019 | -5.621M |
| March 31, 2019 | 6.922M |
| December 31, 2018 | 28.92M |
| September 30, 2018 | 8.869M |
| Date | Value |
|---|---|
| June 30, 2018 | -4.392M |
| March 31, 2018 | 38.52M |
| December 31, 2017 | 38.82M |
| September 30, 2017 | 43.50M |
| June 30, 2017 | 24.70M |
| March 31, 2017 | 18.96M |
| December 31, 2016 | 36.31M |
| September 30, 2016 | 20.12M |
| June 30, 2016 | 8.216M |
| March 31, 2016 | 24.72M |
| December 31, 2015 | 8.11M |
| September 30, 2015 | 1.627M |
| June 30, 2015 | -15.00M |
| March 31, 2015 | 33.62M |
| December 31, 2014 | -2.765M |
| September 30, 2014 | -2.545M |
| June 30, 2014 | -23.35M |
| March 31, 2014 | 21.54M |
| December 31, 2013 | 29.77M |
| September 30, 2013 | 14.25M |
| June 30, 2013 | 0.31M |
| March 31, 2013 | 15.04M |
| December 31, 2012 | 8.712M |
| September 30, 2012 | 7.023M |
| June 30, 2012 | -7.888M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-40.36M
Minimum
Dec 2023
90.01M
Maximum
Sep 2023
26.34M
Average
34.35M
Median
Free Cash Flow (Quarterly) Benchmarks
| Boston Scientific Corp | 698.00M |
| Baxter International Inc | 229.00M |
| Globus Medical Inc | 161.70M |
| Becton Dickinson & Co | 883.00M |
| Insulet Corp | 69.40M |